Drug resistance in brain diseases and the role of drug efflux transporters

W Löscher, H Potschka - Nature Reviews Neuroscience, 2005 - nature.com
Resistance to drug treatment is an important hurdle in the therapy of many brain disorders,
including brain cancer, epilepsy, schizophrenia, depression and infection of the brain with HIV…

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

W Löscher, H Potschka - Progress in neurobiology, 2005 - Elsevier
The blood–brain barrier (BBB) serves as a protective mechanism for the brain by preventing
entry of potentially harmful substances from free access to the central nervous system (CNS)…

Canine epilepsy as a translational model?

H Potschka, A Fischer, EL von Rüden, V Hülsmeyer… - …, 2013 - Wiley Online Library
Dogs with spontaneous diseases can exhibit a striking similarity in etiology, clinical manifestation,
and disease course when compared to human patients. Therefore, dogs are intensely …

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

W Löscher, H Potschka - Journal of pharmacology and experimental …, 2002 - ASPET
Epilepsy, one of the most common neurologic disorders, is a major public health issue. Despite
more than 20 approved antiepileptic drugs (AEDs), about 30% of patients are refractory …

Anticonvulsant effects of transcranial direct‐current stimulation (tDCS) in the rat cortical ramp model of focal epilepsy

…, D Hering, R Koch, MA Nitsche, H Potschka… - …, 2006 - Wiley Online Library
Purpose: Weak direct currents induce lasting alterations of cortical excitability in animals
and humans, which are controlled by polarity, duration of stimulation, and current strength …

Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy

M Glien, C Brandt, H Potschka, W Löscher - Epilepsia, 2002 - Wiley Online Library
Purpose: Animal models in which seizures are elicited by chemical or electrical means are
commonly used for identification and preclinical testing of novel antiepileptic drugs (AEDs). …

[BOOK][B] Pharmakotherapie bei Haus-und Nutztieren: Begründet von W. Löscher, FR Ungemach und R. Kroker

W Löscher, A Richter, H Potschka - 2014 - books.google.com
Welches Analgetikum passt zu meinem Patienten? Mit welchen Nebenwirkungen muss ich
rechnen? Und in welchem Fall sollte ich von der Verwendung Abstand nehmen? Gründlich …

Pharmakologie des zentralen Nervensystems (ZNS)

H Ammer, H Potschka - Lehrbuch der Pharmakologie und …, 2010 - thieme-connect.com
▪ Unterdrückung von angstassoziierten Verhaltensweisen (Trennung, Reise) bei Kleintieren
(Antidepressiva) Verschiedene generelle Gesichtspunkte müssen bei der Verabreichung …

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

W Löscher, H Potschka - NeuroRx, 2005 - Elsevier
The blood-brain barrier (BBB) contributes to brain homeostasis by protecting the brain from
potentially harmful endogenous and exogenous substances. BBB active drug efflux …

Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options

W Löscher, H Potschka, SM Sisodiya, A Vezzani - Pharmacological reviews, 2020 - ASPET
Epilepsy is a chronic neurologic disorder that affects over 70 million people worldwide. Despite
the availability of over 20 antiseizure drugs (ASDs) for symptomatic treatment of epileptic …